With the exception of pSS patients with clinically active disease, all pSS subgroups had higher frequency of CD19+/CD38hi/IgA+/IL-10+ B cells compared with the healthy control group (P < 0.05) (Table 2; Figure 3L). This evidence concerns the gene CD19 and peeling skin syndrome.